Wednesday, October 28, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Cary firm recalls GLP-1 injections following FDA scrutiny

DO

By Daniel Okafor · Regulatory Correspondent

Oct 28 14:53 ETSource: The Business Journals

From the source

Cary firm recalls GLP-1 injections following FDA scrutiny

Read at bizjournals.com

Source URL https://www.bizjournals.com/triangle/news/2026/10/28/apothecary-pharma-recall-tirzepatide-fda-glp1.html

Prescribed peptides from $99/moSee all →